Recent studies in human and animals have shown that both lipocalin-2 [9], [10], [11] and RBP4 [7], [12] are modulators of insulin signaling and their levels are elevated in subjects with obesity, insulin resistance, or type 2 diabetes. The gene discussed is LCN2; the disease is Insulin resistance.